✦ LIBER ✦

Phase I clinical study of anti-apoptosis protein, survivin-derived peptide vaccine therapy for patients with advanced or recurrent colorectal cancer

✍ Scribed by Tetsuhiro Tsuruma; Fumitake Hata; Toshihiko Torigoe; Tomohisa Furuhata; Satomi Idenoue; Takehiro Kurotaki; Masaaki Yamamoto; Atsuhito Yagihashi; Tosei Ohmura; Koji Yamaguchi; Tadashi Katsuramaki; Takahiro Yasoshima; Kazuaki Sasaki; Yasuhiro Mizushima; Hidetoshi Minamida; Hiromichi Kimura; Morifumi Akiyama; Yoshihiko Hirohashi; Hiroko Asanuma; Yasuaki Tamura; Kumiko Shimozawa; Noriyuki Sato; Koichi Hirata

Book ID: 119905356
Publisher: BioMed Central
Year: 2004
Tongue: English
Weight: 832 KB
Volume: 2
Category: Article
ISSN: 1479-5876
DOI: 10.1186/1479-5876-2-19

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I clinical study of anti-apoptosis

Phase I clinical study of anti-apoptosis protein survivin-derived peptide vaccination for patients with advanced or recurrent urothelial cancer

✍ Ichiya Honma; Hiroshi Kitamura; Toshihiko Torigoe; Akari Takahashi; Toshiaki Tan 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 424 KB

Clinical and immunological evaluation of

Clinical and immunological evaluation of anti-apoptosis protein, survivin-derived peptide vaccine in phase I clinical study for patients with advanced or recurrent breast cancer

✍ Tetsuhiro Tsuruma; Yuji Iwayama; Tosei Ohmura; Tadashi Katsuramaki; Fumitake Hat 📂 Article 📅 2008 🏛 BioMed Central 🌐 English ⚖ 636 KB

Phase I clinical trial of survivin-deriv

Phase I clinical trial of survivin-derived peptide vaccine therapy for patients with advanced or recurrent oral cancer

✍ Akihiro Miyazaki; Junichi Kobayashi; Toshihiko Torigoe; Yoshihiko Hirohashi; Tak 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 363 KB

663 Phase I clinical study of survivin-d

663 Phase I clinical study of survivin-derived peptide vaccine with interferon alpha therapy for advanced urothelial cancer

✍ T. Tanaka; H. Kitamura; T. Torigoe; Y. Hirohashi; N. Masumori; N. Sato; T. Tsuka 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 155 KB

Immunogenic enhancement and clinical eff

Immunogenic enhancement and clinical effect by type-I interferon of anti-apoptotic protein, survivin-derived peptide vaccine, in advanced colorectal cancer patients

✍ Hidekazu Kameshima; Tetsuhiro Tsuruma; Toshihiko Torigoe; Akari Takahashi; Yoshi 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 525 KB

Phase I clinical trial of vaccination wi

Phase I clinical trial of vaccination with URLC10-derived peptide for patients with advanced esophageal cancer

✍ Ishikawa, Hajime; Imano, Motohiro; Shiraishi, Osamu; Yasuda, Atsushi; Peng, Ying 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 596 KB